Millions of Filipinos are living with interconnected heart, kidney and metabolic conditions, often without knowing they have a disease until it has already progressed.
These conditions, collectively referred to as cardio-renal-metabolic (CRM) diseases, share common risk factors and frequently occur together, creating a growing health and economic burden for patients, families and the healthcare system.
The need for a more integrated approach to prevent and manage these diseases was highlighted at a recent Cardio-Renal-Metabolic Policy Roundtable convened by ACCESS Health International (AHI), together with the German-Philippine Chamber of Commerce and Industry (GPCCI) and the European Chamber of Commerce of the Philippines (ECCP), with support from Boehringer Ingelheim Philippines.
The forum brought together representatives from government, healthcare organizations, patient groups, academia and the private sector, including the Philippine Health Insurance Corporation (PhilHealth), the National Kidney Transplant Institute (NKTI), the Philippine Alliance of Patient Organizations (PAPO) and the Ateneo Policy Center.
Participants discussed policy opportunities to strengthen prevention, early detection, patient access and coordinated long-term care for people with interconnected chronic conditions.
‘Because these conditions do not exist in isolation, protecting our citizens requires investing in early primary care. PhilHealth stands firm in its commitment to expanding financial risk protection, strengthening primary care financing, and ensuring the long-term sustainability of chronic disease management,’ said Atty. Eli Dino D. Santos, executive vice president and chief operating officer of PhilHealth.
A growing health and economic burden
In the Philippines, about one in five people aged 15 and older lives with at least one chronic condition, including hypertension, chronic kidney disease (CKD), diabetes or cardiovascular disease.
The economic impact is also significant. CKD alone was estimated to cost P593.7 billion in 2023, equivalent to 41 percent of the country’s total healthcare expenditure, according to data presented during the roundtable.
Because CKD frequently occurs alongside other CRM conditions, the combined burden can further strain patients and the healthcare system, underscoring the need for stronger prevention, earlier diagnosis and coordinated care.
‘The burden of chronic kidney disease extends beyond direct healthcare costs. It affects patients’ ability to work, creates productivity losses, and impacts families and the healthcare system,’ said Dr. Anthony Russell Villanueva, consultant nephrologist at NKTI.
‘Understanding these costs can help inform interventions and policies that support earlier detection, prevent disease progression, and improve patient outcomes,’ he added.
The roundtable also highlighted the need to strengthen health information systems and disease registries, develop sustainable financing mechanisms and better integrate CRM priorities into national health policies and programs.
The Department of Health (DOH) highlighted its ongoing efforts to address gaps in chronic kidney disease care and expand access to services, while PhilHealth reaffirmed its commitment to strengthening financial protection for sustainable chronic disease management.
From dialogue to action
AHI presented an assessment of CRM policy gaps and opportunities in the Philippines, while representatives from NKTI, PAPO and the Ateneo Policy Center shared insights on the economic burden of CKD and policy recommendations.
Boehringer Ingelheim also provided regional perspectives on integrated CRM care across Asia-Pacific.
For AHI, the discussions should lead to concrete action rather than remain a policy dialogue.
‘No single institution can advance integrated cardio-renal-metabolic care alone. The next step is translating evidence into action by identifying shared priorities, defining responsibilities, and sustaining collaboration across sectors,’ said Dr. Rohini Omkar Prasad, regional director and director for research and advisory at AHI.
‘Through this dialogue, we hope to build consensus on practical steps that can help advance integrated CRM care in the Philippines,’ she added.
The roundtable reflects a growing recognition that heart, kidney and metabolic diseases cannot always be addressed separately. Coordinating prevention, early detection, financing and long-term management could help reduce the burden of these interconnected conditions on Filipino patients and the country’s healthcare system.